コンテンツへスキップ
Merck

The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

PloS one (2019-05-21)
Joana Sales-Dias, Gabriela Silva, Márcia Lamy, Andreia Ferreira, Ana Barbas
要旨

These findings provide further evidence that DLL1 exerts carcinogenic effects in BC cells. The dissimilar effects of DLL1 downregulation observed amongst MCF-7, BT474, and MDA-MB-231 cells is likely due to their distinctive genetic and biologic characteristics, suggesting that DLL1 contributes to BC through various mechanisms.

材料
製品番号
ブランド
製品内容

Roche
cOmplete, EDTA-free Protease Inhibitor Cocktail(EDTA不含プロテアーゼ阻害剤カクテル), Tablets provided in EASYpacks
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
抗α-チューブリン抗体, マウスモノクローナル, clone DM1A, purified from hybridoma cell culture
Sigma-Aldrich
抗ウサギIgG (全分子)-ペルオキシダーゼ ヤギ宿主抗体, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
抗ヤギIgG (全分子)-ペルオキシダーゼ ウサギ宿主抗体, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗マウスIgG (Fc特異的)-ペルオキシダーゼ ヤギ宿主抗体, affinity isolated antibody, buffered aqueous solution